Clinical Trial Update: Bioequivalence Study of Digoxin Tablet in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of a Digoxin tablet in healthy subjects has completed, evaluating formulation equivalence for heart failure treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Digoxin tablet (digoxin)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Heart Failure | Phase 1 | Status: COMPLETED